Bioteque Corporation (4107.TWO)
TWD 110.0
(-0.9%)
TWD 110.0
(-0.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.62 Billion TWD | 3.12% |
| 2022 | 4.48 Billion TWD | 16.05% |
| 2021 | 3.86 Billion TWD | 8.34% |
| 2020 | 3.56 Billion TWD | 21.2% |
| 2019 | 2.94 Billion TWD | 6.1% |
| 2018 | 2.77 Billion TWD | 5.72% |
| 2017 | 2.62 Billion TWD | 2.25% |
| 2016 | 2.56 Billion TWD | 2.4% |
| 2015 | 2.5 Billion TWD | 6.69% |
| 2014 | 2.34 Billion TWD | 17.52% |
| 2013 | 1.99 Billion TWD | 22.78% |
| 2012 | 1.62 Billion TWD | -0.11% |
| 2011 | 1.62 Billion TWD | -3.37% |
| 2010 | 1.68 Billion TWD | -2.44% |
| 2009 | 1.72 Billion TWD | 0.31% |
| 2008 | 1.72 Billion TWD | 4.28% |
| 2007 | 1.65 Billion TWD | 26.11% |
| 2006 | 1.3 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.83 Billion TWD | 1.83% |
| 2024 Q1 | 4.75 Billion TWD | 2.86% |
| 2023 FY | 4.62 Billion TWD | 3.12% |
| 2023 Q3 | 4.49 Billion TWD | -1.88% |
| 2023 Q1 | 4.51 Billion TWD | 0.66% |
| 2023 Q2 | 4.58 Billion TWD | 1.58% |
| 2023 Q4 | 4.62 Billion TWD | 2.78% |
| 2022 Q2 | 4.12 Billion TWD | 3.65% |
| 2022 Q1 | 3.98 Billion TWD | 3.12% |
| 2022 FY | 4.48 Billion TWD | 16.05% |
| 2022 Q3 | 4.27 Billion TWD | 3.68% |
| 2022 Q4 | 4.48 Billion TWD | 4.72% |
| 2021 Q1 | 3.7 Billion TWD | 3.88% |
| 2021 Q3 | 3.63 Billion TWD | -5.34% |
| 2021 Q4 | 3.86 Billion TWD | 6.17% |
| 2021 FY | 3.86 Billion TWD | 8.34% |
| 2021 Q2 | 3.84 Billion TWD | 3.77% |
| 2020 Q3 | 3.35 Billion TWD | 3.64% |
| 2020 Q1 | 3.07 Billion TWD | 4.67% |
| 2020 FY | 3.56 Billion TWD | 21.2% |
| 2020 Q2 | 3.23 Billion TWD | 5.26% |
| 2020 Q4 | 3.56 Billion TWD | 6.14% |
| 2019 Q3 | 2.94 Billion TWD | -4.77% |
| 2019 Q4 | 2.94 Billion TWD | -0.29% |
| 2019 FY | 2.94 Billion TWD | 6.1% |
| 2019 Q2 | 3.09 Billion TWD | 5.95% |
| 2019 Q1 | 2.92 Billion TWD | 5.46% |
| 2018 FY | 2.77 Billion TWD | 5.72% |
| 2018 Q4 | 2.77 Billion TWD | 3.29% |
| 2018 Q1 | 2.71 Billion TWD | 3.63% |
| 2018 Q2 | 2.86 Billion TWD | 5.48% |
| 2018 Q3 | 2.68 Billion TWD | -6.35% |
| 2017 Q4 | 2.62 Billion TWD | 3.61% |
| 2017 Q2 | 2.65 Billion TWD | 3.41% |
| 2017 Q1 | 2.57 Billion TWD | 0.28% |
| 2017 FY | 2.62 Billion TWD | 2.25% |
| 2017 Q3 | 2.53 Billion TWD | -4.83% |
| 2016 FY | 2.56 Billion TWD | 2.4% |
| 2016 Q1 | 2.59 Billion TWD | 3.59% |
| 2016 Q2 | 2.64 Billion TWD | 2.03% |
| 2016 Q3 | 2.49 Billion TWD | -5.7% |
| 2016 Q4 | 2.56 Billion TWD | 2.74% |
| 2015 FY | 2.5 Billion TWD | 6.69% |
| 2015 Q4 | 2.5 Billion TWD | 1.18% |
| 2015 Q3 | 2.47 Billion TWD | -1.32% |
| 2015 Q2 | 2.5 Billion TWD | 2.3% |
| 2015 Q1 | 2.45 Billion TWD | 4.45% |
| 2014 Q1 | 2.09 Billion TWD | 5.15% |
| 2014 FY | 2.34 Billion TWD | 17.52% |
| 2014 Q3 | 2.21 Billion TWD | -1.94% |
| 2014 Q2 | 2.25 Billion TWD | 7.5% |
| 2014 Q4 | 2.34 Billion TWD | 6.02% |
| 2013 Q2 | 1.73 Billion TWD | 1.25% |
| 2013 Q3 | 1.81 Billion TWD | 4.36% |
| 2013 Q4 | 1.99 Billion TWD | 10.15% |
| 2013 FY | 1.99 Billion TWD | 22.78% |
| 2013 Q1 | 1.71 Billion TWD | 5.49% |
| 2012 Q1 | 1.65 Billion TWD | 1.94% |
| 2012 Q2 | 1.66 Billion TWD | 0.04% |
| 2012 Q3 | 1.58 Billion TWD | -4.48% |
| 2012 Q4 | 1.62 Billion TWD | 2.55% |
| 2012 FY | 1.62 Billion TWD | -0.11% |
| 2011 Q2 | 1.7 Billion TWD | 0.66% |
| 2011 Q3 | 1.58 Billion TWD | -7.48% |
| 2011 Q4 | 1.62 Billion TWD | 3.01% |
| 2011 FY | 1.62 Billion TWD | -3.37% |
| 2011 Q1 | 1.69 Billion TWD | 0.72% |
| 2010 Q4 | 1.68 Billion TWD | 0.0% |
| 2010 FY | 1.68 Billion TWD | -2.44% |
| 2009 FY | 1.72 Billion TWD | 0.31% |
| 2008 FY | 1.72 Billion TWD | 4.28% |
| 2007 FY | 1.65 Billion TWD | 26.11% |
| 2006 FY | 1.3 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 7.75 Billion TWD | 40.415% |
| Chi Sheng Pharma & Biotech Co., Ltd | 1.76 Billion TWD | -161.614% |
| Sunder Biomedical Tech. Co., Ltd. | 1.4 Billion TWD | -228.785% |
| BenQ Medical Technology Corporation | 4.71 Billion TWD | 1.948% |
| Pacific Hospital Supply Co., Ltd | 3.76 Billion TWD | -22.625% |
| Unicon Optical Co., Ltd. | 1.53 Billion TWD | -201.722% |
| Formosa Optical Technology Co.,Ltd. | 7.13 Billion TWD | 35.27% |
| Medeon Biodesign, Inc. | 2.74 Billion TWD | -68.188% |
| Concord Medical Co., Ltd. | 1.15 Billion TWD | -301.167% |
| Crystalvue Medical Corporation | 1.07 Billion TWD | -328.437% |
| Perfect Medical Industry Co., Ltd. | 988.48 Million TWD | -367.421% |
| ICARES Medicus, Inc. | 1.9 Billion TWD | -142.074% |
| Lagis Enterprise Co., Ltd. | 845.39 Million TWD | -446.536% |
| Amed Co., Ltd. | 885.85 Million TWD | -421.574% |